{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:29:46Z","timestamp":1793928586315,"version":"4.8.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000886","name":"Duke Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["CTSA Grant #UL1TR002553"],"award-info":[{"award-number":["CTSA Grant #UL1TR002553"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11606-025-09820-z","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:52:00Z","timestamp":1762447920000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of a Hospitalist-Led Consult Service for Patients with Opioid Use Disorder: A Propensity Score Weighted Study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-1279","authenticated-orcid":false,"given":"Dana","family":"Clifton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noppon","family":"Setji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"9820_CR1","unstructured":"Centers for Disease Control and Prevention. Understanding the Opioid Overdose Epidemic: Overdose Prevention. 2024. Available at: https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html. Accessed: 21 May 2024."},{"key":"9820_CR2","unstructured":"Centers for Disease Control and Prevention: National Center for Health Statistics. U.S. Overdose Deaths Decrease in 2023, First Time Since 2018. 2024. Available at: https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm#:~:text=The%20new%20data%20show%20overdose,psychostimulants%20(like%20methamphetamine)%20increased. Accessed 24 Sept 2024"},{"key":"9820_CR3","doi-asserted-by":"publisher","unstructured":"Heimer R, Black AC, Lin H, et al. Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016\u201317. Drug Alcohol Depend. 2024;254:111040.  https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.111040.","DOI":"10.1016\/j.drugalcdep.2023.111040"},{"key":"9820_CR4","doi-asserted-by":"publisher","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Ann Intern Med. 2018;169(3):137\u201345. https:\/\/doi.org\/10.7326\/M17-3107.","DOI":"10.7326\/M17-3107"},{"key":"9820_CR5","doi-asserted-by":"publisher","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","DOI":"10.1136\/bmj.j1550"},{"key":"9820_CR6","doi-asserted-by":"publisher","unstructured":"Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009;105(1\u20132):9\u201315.  https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.05.021.","DOI":"10.1016\/j.drugalcdep.2009.05.021"},{"key":"9820_CR7","doi-asserted-by":"publisher","unstructured":"Ma J, Bao YP, Wang RJ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1868\u201383. https:\/\/doi.org\/10.1038\/s41380-018-0094-5.","DOI":"10.1038\/s41380-018-0094-5"},{"key":"9820_CR8","unstructured":"Substance Abuse and Mental Health Services Administration. Waiver Elimination (MAT Act). 2023. Available at: https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/waiver-elimination-mat-act. Accessed 3 Apr 2024."},{"key":"9820_CR9","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine 2019. Medications for Opioid Use Disorder Saves Lives. Washington, DC: The National Academies Press, https:\/\/doi.org\/10.17226\/25310.","DOI":"10.17226\/25310"},{"key":"9820_CR10","doi-asserted-by":"publisher","unstructured":"Calcaterra SL, Martin M, Bottner R, et al. Management of opioid use disorder and associated conditions among hospitalized adults: a consensus statement from the society of hospital medicine. J Hosp Med. 2022;17(9):744\u201356. https:\/\/doi.org\/10.1002\/jhm.12893.","DOI":"10.1002\/jhm.12893"},{"key":"9820_CR11","doi-asserted-by":"crossref","unstructured":"Jones CM, Han B, Baldwin GT, Einstein EB, Compton WM. Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021. JAMA Netw Open. 2023;6(8):e2327488.","DOI":"10.1001\/jamanetworkopen.2023.27488"},{"key":"9820_CR12","unstructured":"Substance Abuse and Mental Health Services Administration. Medications for the Treatment of Opioid Use Disorder. Federal Register: National Archives and Records Administration, 2024 February 2, 2024. Report No.: 2024\u201301693."},{"key":"9820_CR13","doi-asserted-by":"publisher","unstructured":"Incze MA, Huebler S, Baylis JD, et al. Mortality Among Veterans With Opioid Use Disorder After Medical Hospitalization. JAMA Intern Med. 2025. https:\/\/doi.org\/10.1001\/jamainternmed.2025.0356.","DOI":"10.1001\/jamainternmed.2025.0356"},{"key":"9820_CR14","doi-asserted-by":"publisher","unstructured":"Bernstein EY, Calcaterra SL, Chopra V, Edelman EJ, Kruse GR. Prevalence of Hospitalizations Among a National Sample of U.S. Adults With Substance Use Disorders. Ann Intern Med. 2025. https:\/\/doi.org\/10.7326\/ANNALS-24-03385.","DOI":"10.7326\/ANNALS-24-03385"},{"key":"9820_CR15","doi-asserted-by":"publisher","unstructured":"Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O\u2019Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2022;43(1):143\u201351. https:\/\/doi.org\/10.1080\/08897077.2020.1748169.","DOI":"10.1080\/08897077.2020.1748169"},{"key":"9820_CR16","doi-asserted-by":"publisher","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1\u20135. Epub 2017\/07\/05. https:\/\/doi.org\/10.1016\/j.jsat.2017.05.007.","DOI":"10.1016\/j.jsat.2017.05.007"},{"key":"9820_CR17","doi-asserted-by":"publisher","unstructured":"Englander H, Dobbertin K, Lind BK, et al. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis. J Gen Intern Med. 2019;34(12):2796\u2013803. https:\/\/doi.org\/10.1007\/s11606-019-05251-9.","DOI":"10.1007\/s11606-019-05251-9"},{"key":"9820_CR18","doi-asserted-by":"crossref","unstructured":"Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369\u201376.","DOI":"10.1001\/jamainternmed.2014.2556"},{"key":"9820_CR19","doi-asserted-by":"publisher","unstructured":"Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity. J Gen Intern Med. 2017;32(8):909\u201316. https:\/\/doi.org\/10.1007\/s11606-017-4077-z.","DOI":"10.1007\/s11606-017-4077-z"},{"key":"9820_CR20","doi-asserted-by":"crossref","unstructured":"Velez CM, Nicolaidis C, Korthuis PT, Englander H. \u201cIt\u2019s been an Experience, a Life Learning Experience\u201d: A Qualitative Study of Hospitalized Patients with Substance Use Disorders. J Gen Intern Med. 2017;32(3):296\u2013303.","DOI":"10.1007\/s11606-016-3919-4"},{"key":"9820_CR21","doi-asserted-by":"publisher","unstructured":"McNeely J, Wang SS, Rostam Abadi Y, et al. Addiction consultation services for opioid use disorder treatment initiation and engagement: a randomized clinical trial. JAMA Intern Med. 2024;184(9):1106-15. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3422.","DOI":"10.1001\/jamainternmed.2024.3422"},{"key":"9820_CR22","doi-asserted-by":"publisher","unstructured":"Ober AJ, Murray-Krezan C, Page K, et al. Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial. JAMA Intern Med. 2025.  https:\/\/doi.org\/10.1001\/jamainternmed.2024.8586.","DOI":"10.1001\/jamainternmed.2024.8586"},{"key":"9820_CR23","doi-asserted-by":"publisher","unstructured":"Englander H, King C, Nicolaidis C, et al. Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service. J Addict Med. 2020;14(5):415-22. https:\/\/doi.org\/10.1097\/ADM.0000000000000611.","DOI":"10.1097\/ADM.0000000000000611"},{"key":"9820_CR24","doi-asserted-by":"publisher","unstructured":"Tierney HR, Rowe CL, Coffa DA, Sarnaik S, Coffin PO, Snyder HR. Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge. J Addict Med. 2022;16(2):169-76. https:\/\/doi.org\/10.1097\/ADM.0000000000000851.","DOI":"10.1097\/ADM.0000000000000851"},{"key":"9820_CR25","doi-asserted-by":"publisher","unstructured":"Nordeck CD, Welsh C, Schwartz RP, Mitchell SG, O\u2019Grady KE, Gryczynski J. Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug Alcohol Depend Rep. 2022;2:100031. https:\/\/doi.org\/10.1016\/j.dadr.2022.100031.","DOI":"10.1016\/j.dadr.2022.100031"},{"key":"9820_CR26","doi-asserted-by":"publisher","unstructured":"Kimmel SD, Walley AY, Li Y, et al. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis. JAMA Netw Open. 2020;3(10):e2016228. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.16228.","DOI":"10.1001\/jamanetworkopen.2020.16228"},{"key":"9820_CR27","doi-asserted-by":"publisher","unstructured":"Wilson JD, Altieri Dunn SC, Roy P, Joseph E, Klipp S, Liebschutz J. Inpatient Addiction Medicine Consultation Service Impact on Post-discharge Patient Mortality: a Propensity-Matched Analysis. J Gen Intern Med. 2022;37(10):2521\u20135. https:\/\/doi.org\/10.1007\/s11606-021-07362-8.","DOI":"10.1007\/s11606-021-07362-8"},{"key":"9820_CR28","doi-asserted-by":"publisher","unstructured":"Christian N, Bottner R, Baysinger A, et al. Hospital Buprenorphine Program for Opioid use disorder is associated with increased inpatient and outpatient addiction treatment. J Hosp Med. 2021;16(6):345\u20138.https:\/\/doi.org\/10.12788\/jhm.3591.","DOI":"10.12788\/jhm.3591"},{"key":"9820_CR29","doi-asserted-by":"publisher","unstructured":"Thakrar AP, Furfaro D, Keller S, Graddy R, Buresh M, Feldman L. A Resident-Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder. J Hosp Med. 2021;16(6):339\u201344.  https:\/\/doi.org\/10.12788\/jhm.3544.","DOI":"10.12788\/jhm.3544"},{"key":"9820_CR30","doi-asserted-by":"publisher","unstructured":"Zavodnick J, Heinsinger NM, Lepore AC, Sterling RC. Medication initiation, patient-directed discharges, and hospital readmissions before and after implementing guidelines for Opioid Withdrawal Management. J Addict Med. 2023;17(1):e57-e63. https:\/\/doi.org\/10.1097\/ADM.0000000000001053.","DOI":"10.1097\/ADM.0000000000001053"},{"key":"9820_CR31","doi-asserted-by":"publisher","unstructured":"Kays LB, Steltenpohl ED, McPheeters CM, Frederick EK, Bishop LB. Initiation of Buprenorphine\/Naloxone on Rates of Discharge Against Medical Advice. Hosp Pharm. 2022;57(1):88\u201392. https:\/\/doi.org\/10.1177\/0018578720985439.","DOI":"10.1177\/0018578720985439"},{"key":"9820_CR32","doi-asserted-by":"publisher","unstructured":"Wang SJ, Wade E, Towle J, et al. Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates. Am J Med. 2020;133(11):1343\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2020.04.025.","DOI":"10.1016\/j.amjmed.2020.04.025"},{"key":"9820_CR33","doi-asserted-by":"publisher","unstructured":"Clifton D, Ivey N, Poley S, et al. Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder. J Hosp Med. 2022;17(6):427\u201336. https:\/\/doi.org\/10.1002\/jhm.12837.","DOI":"10.1002\/jhm.12837"},{"key":"9820_CR34","doi-asserted-by":"crossref","unstructured":"Hurst JH, Liu Y, Maxson PJ, Permar SR, Boulware LE, Goldstein BA. Development of an electronic health records datamart to support clinical and population health research. J Clin Transl Sci. 2020;5(1):e13. Epub 20200623. doi: 10.1017\/cts.2020.499. PubMed PMID: 33948239.","DOI":"10.1017\/cts.2020.499"},{"key":"9820_CR35","doi-asserted-by":"publisher","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015;12(10):e1001885. https:\/\/doi.org\/10.1371\/journal.pmed.1001885.","DOI":"10.1371\/journal.pmed.1001885"},{"key":"9820_CR36","unstructured":"Weiss AJ, Heslin KC, Stocks C, Owens PL. Hospital Inpatient Stays Related to Opioid Use Disorder and Endocarditis, 2016. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)2006."},{"key":"9820_CR37","doi-asserted-by":"publisher","unstructured":"Tsybina P, Kassir S, Clark M, Skinner S. Hospital admissions and mortality due to complications of injection drug use in two hospitals in Regina, Canada: retrospective chart review. Harm Reduct J. 2021;18(1):44.  https:\/\/doi.org\/10.1186\/s12954-021-00492-6.","DOI":"10.1186\/s12954-021-00492-6"},{"key":"9820_CR38","doi-asserted-by":"publisher","unstructured":"Ronan MV, Herzig SJ. Hospitalizations Related To Opioid Abuse\/Dependence And Associated Serious Infections Increased Sharply, 2002\u201312. Health Aff (Millwood). 2016;35(5):832\u20137. Epub 2016\/05\/04. https:\/\/doi.org\/10.1377\/hlthaff.2015.1424.","DOI":"10.1377\/hlthaff.2015.1424"},{"key":"9820_CR39","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"9820_CR40","doi-asserted-by":"publisher","unstructured":"Schranz AJ, Tak C, Wu LT, Chu VH, Wohl DA, Rosen DL. The Impact of Discharge Against Medical Advice on Readmission After Opioid Use Disorder-Associated Infective Endocarditis: a National Cohort Study. J Gen Intern Med. 2023;38(7):1615\u201322.  https:\/\/doi.org\/10.1007\/s11606-022-07879-6.","DOI":"10.1007\/s11606-022-07879-6"},{"key":"9820_CR41","doi-asserted-by":"publisher","unstructured":"Tan SY, Feng JY, Joyce C, Fisher J, Mostaghimi A. Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital Mortality. JAMA Netw Open. 2020;3(6):e206009. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.6009.","DOI":"10.1001\/jamanetworkopen.2020.6009"},{"key":"9820_CR42","doi-asserted-by":"publisher","unstructured":"Thakrar AP, Lowenstein M, Greysen SR, Delgado MK. Trends in before medically advised discharges for patients with opioid use disorder, 2016-2020. JAMA. 2023;330(23):2302-4. https:\/\/doi.org\/10.1001\/jama.2023.21288.","DOI":"10.1001\/jama.2023.21288"},{"key":"9820_CR43","doi-asserted-by":"publisher","unstructured":"Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020;41(4):519\u201325. https:\/\/doi.org\/10.1080\/08897077.2019.1671942.","DOI":"10.1080\/08897077.2019.1671942"},{"key":"9820_CR44","doi-asserted-by":"publisher","unstructured":"Li F, Thomas LE, Li F. Addressing Extreme Propensity Scores via the Overlap Weights. Am J Epidemiol. 2019;188(1):250-7.  https:\/\/doi.org\/10.1093\/aje\/kwy201. PubMed PMID: 30189042.","DOI":"10.1093\/aje\/kwy201"},{"key":"9820_CR45","doi-asserted-by":"publisher","unstructured":"Feeney C, Chandler M, Platt A, Sun S, Setji N, Ming DY. Impact of a hospital service for adults with chronic childhood-onset disease: A propensity weighted analysis. J Hosp Med. 2023;18(12):1082\u201391. https:\/\/doi.org\/10.1002\/jhm.13234.","DOI":"10.1002\/jhm.13234"},{"key":"9820_CR46","doi-asserted-by":"publisher","unstructured":"Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456\u20138. https:\/\/doi.org\/10.1056\/NEJMp1802313.","DOI":"10.1056\/NEJMp1802313"},{"key":"9820_CR47","unstructured":"University of Wisconsin School of Medicine and Public Health. Area Deprivation Index. 2020. Available at: https:\/\/www.neighborhoodatlas.medicine.wisc.edu. Accessed 9 Aug 2023."},{"key":"9820_CR48","doi-asserted-by":"publisher","unstructured":"Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index. Med Care. 2017;55(7):698-705. https:\/\/doi.org\/10.1097\/MLR.0000000000000735.","DOI":"10.1097\/MLR.0000000000000735"},{"key":"9820_CR49","doi-asserted-by":"publisher","unstructured":"Barnett ML, Meara E, Lewinson T, et al. Racial Inequality in Receipt of Medications for Opioid Use Disorder. N Engl J Med. 2023;388(19):1779-89. https:\/\/doi.org\/10.1056\/NEJMsa2212412.","DOI":"10.1056\/NEJMsa2212412"},{"key":"9820_CR50","doi-asserted-by":"publisher","unstructured":"Hollander MAG, Chang CH, Douaihy AB, Hulsey E, Donohue JM. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use. Drug Alcohol Depend. 2021;227:108927. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108927.","DOI":"10.1016\/j.drugalcdep.2021.108927"},{"key":"9820_CR51","unstructured":"Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS. 2012. Available at: https:\/\/www.semanticscholar.org\/paper\/A-unified-approach-to-measuring-the-effect-size-two-Yang-Dalton\/6cf4bd36ca4c90006a5d6563f646a391c255581b. Accessed 29 Apr 2025."},{"key":"9820_CR52","doi-asserted-by":"publisher","unstructured":"Cho Y, Hu C, Ghosh D. Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model. Stat Med. 2018;37(3):390\u2013404.  https:\/\/doi.org\/10.1002\/sim.7513.","DOI":"10.1002\/sim.7513"},{"key":"9820_CR53","doi-asserted-by":"publisher","unstructured":"Nordeck CD, Welsh C, Schwartz RP, et al. Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service. Drug Alcohol Depend. 2018;186:23\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.043.","DOI":"10.1016\/j.drugalcdep.2017.12.043"},{"key":"9820_CR54","doi-asserted-by":"publisher","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636-44. https:\/\/doi.org\/10.1001\/jama.2015.3474.","DOI":"10.1001\/jama.2015.3474"},{"key":"9820_CR55","doi-asserted-by":"publisher","unstructured":"Roy PJ, Price R, Choi S, et al. Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge. Drug Alcohol Depend. 2021;224:108703. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108703.","DOI":"10.1016\/j.drugalcdep.2021.108703"},{"key":"9820_CR56","doi-asserted-by":"publisher","unstructured":"Wakeman SE, Rigotti NA, Herman GE, et al. The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial. Subst Abus. 2021;42(4):646\u201353.  https:\/\/doi.org\/10.1080\/08897077.2020.1809608.","DOI":"10.1080\/08897077.2020.1809608"},{"key":"9820_CR57","doi-asserted-by":"publisher","unstructured":"Smith A, Hansen J, Colvard M. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention. J Subst Abuse Treat. 2021;130:108440.  https:\/\/doi.org\/10.1016\/j.jsat.2021.108440.","DOI":"10.1016\/j.jsat.2021.108440"},{"key":"9820_CR58","doi-asserted-by":"publisher","unstructured":"Byrne KA, Roth PJ, Merchant K, et al. Inpatient link to peer recovery coaching: Results from a pilot randomized control trial. Drug Alcohol Depend. 2020;215:108234.  https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108234.","DOI":"10.1016\/j.drugalcdep.2020.108234"},{"key":"9820_CR59","doi-asserted-by":"publisher","unstructured":"Cupp JA, Byrne KA, Herbert K, Roth PJ. Acute Care Utilization After Recovery Coaching Linkage During Substance-Related Inpatient Admission: Results of Two Randomized Controlled Trials. J Gen Intern Med. 2022;37(11):2768\u201376.  https:\/\/doi.org\/10.1007\/s11606-021-07360-w.","DOI":"10.1007\/s11606-021-07360-w"},{"key":"9820_CR60","doi-asserted-by":"publisher","unstructured":"Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O\u2019Grady KE, Schwartz RP. Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder : A Randomized Trial. Ann Intern Med. 2021;174(7):899\u2013909. Epub 2021\/04\/06.  https:\/\/doi.org\/10.7326\/M20-5475.","DOI":"10.7326\/M20-5475"},{"key":"9820_CR61","doi-asserted-by":"publisher","unstructured":"James H, Morgan J, Ti L, Nolan S. Transitions in care between hospital and community settings for individuals with a substance use disorder: A systematic review. Drug Alcohol Depend. 2023;243:109763. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109763.","DOI":"10.1016\/j.drugalcdep.2023.109763"},{"key":"9820_CR62","doi-asserted-by":"publisher","unstructured":"Zang X, Skinner A, Krieger MS, et al. Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement. JAMA Netw Open. 2024;7(5):e2413861. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.13861.","DOI":"10.1001\/jamanetworkopen.2024.13861"},{"key":"9820_CR63","doi-asserted-by":"publisher","unstructured":"Englander H, Jones A, Krawczyk N, et al. A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews. J Gen Intern Med. 2022;37(11):2821\u201333. https:\/\/doi.org\/10.1007\/s11606-022-07618-x.","DOI":"10.1007\/s11606-022-07618-x"},{"key":"9820_CR64","doi-asserted-by":"publisher","unstructured":"Moreno JL, Wakeman SE, Duprey MS, Roberts RJ, Jacobson JS, Devlin JW. Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder. J Addict Med. 2019;13(4):306\u201313. https:\/\/doi.org\/10.1097\/ADM.0000000000000499.","DOI":"10.1097\/ADM.0000000000000499"},{"key":"9820_CR65","doi-asserted-by":"publisher","unstructured":"Thompson HM, Hill K, Jadhav R, Webb TA, Pollack M, Karnik N. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019;13(6):460-3. https:\/\/doi.org\/10.1097\/ADM.0000000000000520.","DOI":"10.1097\/ADM.0000000000000520"},{"key":"9820_CR66","doi-asserted-by":"publisher","unstructured":"Blanchard J, Weiss AJ, Barrett ML, et al. Readmissions Following Inpatient Treatment for Opioid-Related Conditions. Subst Use Misuse. 2019;54(3):473\u201381. https:\/\/doi.org\/10.1080\/10826084.2018.1517174.","DOI":"10.1080\/10826084.2018.1517174"},{"key":"9820_CR67","doi-asserted-by":"publisher","unstructured":"Weinstein ZM, Cheng DM, D\u2019Amico MJ, et al. Inpatient addiction consultation and post-discharge 30-day acute care utilization. Drug Alcohol Depend. 2020;213:108081.   https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108081.","DOI":"10.1016\/j.drugalcdep.2020.108081"},{"key":"9820_CR68","doi-asserted-by":"publisher","unstructured":"Howell BA, Abel EA, Park D, Edmond SN, Leisch LJ, Becker WC. Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study. J Gen Intern Med. 2021;36(5):1264\u201370. https:\/\/doi.org\/10.1007\/s11606-020-06339-3.","DOI":"10.1007\/s11606-020-06339-3"},{"key":"9820_CR69","doi-asserted-by":"publisher","unstructured":"Palumbo SA, Adamson KM, Krishnamurthy S, et al. Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation. JAMA Netw Open. 2020;3(9):e2015909. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.15909.","DOI":"10.1001\/jamanetworkopen.2020.15909"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09820-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09820-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09820-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:03:32Z","timestamp":1793927012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09820-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9820"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09820-z","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DC and NI received internal grants and honoraria for OUD-related lectures at hospitals and conferences. DC received an American Academy of Pediatrics stipend for a QI project on improving discharge for infants with neonatal opioid withdrawal syndrome.","order":1,"name":"Ethics","label":"Conflict of Interest:","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study was determined exempt by the DUHS IRB.","order":2,"name":"Ethics","label":"Ethics Approval and Consent to Participate:","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}